N
Google TrendKINGS VS GOLDEN KNIGHTS (500+) — 10/10 Preview - Depth Tested Early + Morning Skate Notes, 36/15 to IR, Wright Extension, PK Looks To Build on Tuesday
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:kings vs golden knights500+penta wwe200+jonas brothers500+steven kwan500+manny ramirez500+hogwarts legacy 2200+justin edwards200+steffi graf200+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "HER2DX in older patients" (11 stories)

Top Headline Story

HER2DX in older patients with HER2-positive early breast cancer: extended follow-up from the RESPECT trial of trastuzumab ± chemotherapy
Lead StoryNaturegeneral
Nov 4, 2025

HER2DX in older patients with HER2-positive early breast cancer: extended follow-up from the RESPECT trial of trastuzumab ± chemotherapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFByYTRac1hvUFNtSHBGQlpiTVJ5N3dVUlp5b1pLTTdabUVEM2tjcndudmN0LVY2d0V5YnlIR3c0NkR3WkhBMlhGVDQ4V25xbExsci1HSjBaWHVyZ3ZOVnpV?oc=5" target="_blank">HER2DX in older patients with HER2-positive early breast cancer: extended follow-up from the RESPECT trial of trastuzumab ± chemotherapy</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
500+16m ago

kings vs golden knights

10/10 Preview - Depth Tested Early + Morning Skate Notes, 36/15 to IR, Wright Extension, PK Looks To Build on Tuesday

Filter stories
200+16m ago

penta wwe

Penta vs. Roman Reigns Tops WWE YouTube Videos For September

Filter stories
500+26m ago

jonas brothers

Jonas Brothers postpone Birmingham concert over weather concerns

Filter stories
500+26m ago

steven kwan

Guardians' Steven Kwan Could Shake Up Winter Outfield Market

Filter stories

Search Results for "HER2DX in older patients"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

10 stories displayed
HER2DX Could Aid Chemotherapy Decision-Making in HER2+ Early-Stage Breast Cancer
OncLivetech

HER2DX Could Aid Chemotherapy Decision-Making in HER2+ Early-Stage Breast Cancer

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxQdVk2V1hSWlJob0txbFBFUzlLZEVRenNaNHh1N09HNnBPalJnckQ2MU4xWlA1Wmdqb0lqUUtsQ1lqUzhzYzZLekJ6TEoxM3NZdldKNkI0THN2Y0FHODJ6R0Z4alBrbXhGWi1wbV9Rc2NQejhrZVlPWlVRbnJjR3JObDhoUldxR09ydTNtdkJHTFRUbTJzVXE5cExiUFR1MFFFSDV1ZG8wQ2dLWjNLb29Hb3pvaWE?oc=5" target="_blank">HER2DX Could Aid Chemotherapy Decision-Making in HER2+ Early-Stage Breast Cancer</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
HER2DX in Early HER2-Positive Breast Cancer: Toward Biology-Guided Treatment Intensity
Oncodailygeneral

HER2DX in Early HER2-Positive Breast Cancer: Toward Biology-Guided Treatment Intensity

<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBtUnFVZDdRUkRnbDhiZUNjZlhSLWhaU1RqNG5ZVkdjZC1XVGllSTQwMzJneFVMR2NIZmlxLUdPUG5UOHYwT2EtbUdGM09jc3dLRWkzdnRjQWowRFMwM1NpdHlfQS1TYWh5dURR?oc=5" target="_blank">HER2DX in Early HER2-Positive Breast Cancer: Toward Biology-Guided Treatment Intensity</a>  <font color="#6f6f6f">Oncodaily</font>

Read Full StoryMore like this
Real-world outcomes of early-stage HER2-positive breast cancer patients treated with adjuvant paclitaxel and trastuzumab
Natureworld

Real-world outcomes of early-stage HER2-positive breast cancer patients treated with adjuvant paclitaxel and trastuzumab

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9wODljMDRpZlV6TzdQaEV1bmY4Z3FkUGJZYWtsc3hkNW45ODBzLTZWX2RpNDVkWURxeUF3aGozc0pHOEJEN0NTakh3SjdReVlMUFJXT0F1N3pfd3Jjenhv?oc=5" target="_blank">Real-world outcomes of early-stage HER2-positive breast cancer patients treated with adjuvant paclitaxel and trastuzumab</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
HER2DX Adds Prognostic Precision in Early HER2+ Breast Cancer
DocWireNewsgeneral

HER2DX Adds Prognostic Precision in Early HER2+ Breast Cancer

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxNcUhlX3NIQXo5MHFvMGRxQ2V6anpDNXVMNldwOGI4cS1vVnJ4enUwc2F6RXZZMjFFZ2Q3aktuYzliQTJEb2xMekVBU1JVYkZDOVprdmpSZHBUQmloS202QU4wTkRuU0YybFRLWk83QV94SU9rdmlVWG44ZFlFODNTR083OG0weW1yOVVFS1FWeGNvWUVfbUc0Tg?oc=5" target="_blank">HER2DX Adds Prognostic Precision in Early HER2+ Breast Cancer</a>  <font color="#6f6f6f">DocWireNews</font>

Read Full StoryMore like this
ASCO 2025: REVEAL GENOMICS Unveils New HER2DX Data From 800+ Patients
BioSpaceworld

ASCO 2025: REVEAL GENOMICS Unveils New HER2DX Data From 800+ Patients

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxNX09ta1NhU2FsS3pvTF81NTJsYzl3eldNZDNTem9qU2JyajctcHdiZm5Ea3FTWTN3MXFlaWMzb3BmdUhCdHVQMjdTUmJGeHduQWx2QjdfN3JWcWlXWHJYcmZLRlJUTVFRNnFJcl95Yk5qUnBSWVRpZlItSWt2ejlLaWpkUzBqUDl4Z2VFMDMtUWR1ZHBkNTBzbHMzU1FrZ0pDS2t0OXJndmRDU0E?oc=5" target="_blank">ASCO 2025: REVEAL GENOMICS Unveils New HER2DX Data From 800+ Patients</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis
The Lancetgeneral

HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxNMXY3c2lsYXpENzl3RlFEc1QwUmZ0anI5VkJZdUZoSGd3bURXYzMybkJnNUFWRWVSRXVjeHZnMXlSdnBBUE5vbVJ3Z2FYbi1uc2JhYlJMbEd1LWZmbm9CM0c1Y0FQaXlIZC1lbWI5MEY5UlFqczJlWmtqeFlGOXdhRVZZVnhOcXZxVnhJ?oc=5" target="_blank">HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis</a>  <font color="#6f6f6f">The Lancet</font>

Read Full StoryMore like this
HER2DX Demonstrates Clinical Promise Among Patients With HER2-Positive Early Breast Cancer
HMP Global Learning Networkgeneral

HER2DX Demonstrates Clinical Promise Among Patients With HER2-Positive Early Breast Cancer

<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxPNC1oTklkNnJEeFhydTdzZ0lHVG9RZnVrbjNkTm55ZmVGZzRIVUZvYnhwTkVncDlsdnlFQ1p3R3NUQUtmaDdiWVZPNjNUZl8tMXRtX3RkWk5xNE1nMzQzV0NvaVB4ajk5V2xEb1JCSGZpWGFFVzlUY3NSeTR2YmJzTDhGLXRUck4wRjFrV0RGbHZkUzNncGEwemo1ZURPV2FDYmM2ZmNLcGV0NFJOVWZrQ3lYTUhFcDdDWm43SkRzMEw1OVhMVmVZYjhvR3Zab1M2?oc=5" target="_blank">HER2DX Demonstrates Clinical Promise Among Patients With HER2-Positive Early Breast Cancer</a>  <font color="#6f6f6f">HMP Global Learning Network</font>

Read Full StoryMore like this
HER2+ Early Breast Cancer: Who Can Safely Receive Less?
Medscapegeneral

HER2+ Early Breast Cancer: Who Can Safely Receive Less?

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxPN0hCb3RmUE1sS0FaNklCQXpfRUx6MHRYYkZBdXh5aUhsbTZGQTR4cU9US2FCbjBtaXZ4eVFTWVdWUEptWHVZYWFuSDdPZEw2THE2UHQtbi1nM1FMSEZienV6UXJkb2xrSWRvY3lVUkcwQzN4Q0ZzUy0zRTdMeE44RlpGX05WZE9YYURwRU9TQ1BPM1A2TzdydmlWalVYLUUyM2NETzRDbUU?oc=5" target="_blank">HER2+ Early Breast Cancer: Who Can Safely Receive Less?</a>  <font color="#6f6f6f">Medscape</font>

Read Full StoryMore like this
Reveal Genomics® to Evaluate Prospective Real-time Performance of HER2DX® Genomic Test in the United States
Business Wireworld

Reveal Genomics® to Evaluate Prospective Real-time Performance of HER2DX® Genomic Test in the United States

<a href="https://news.google.com/rss/articles/CBMi9AFBVV95cUxQTmEteFprUUh3NTNmRl9MakxGNFBSODRKREdZOVZyYzZLUmRrS0hNMk1jUEo4SHFKNlo0Tko0MS16SS1jbHRfMFhLMHpCQi1yWFdaSGNQYUxacFlfVGFwMnVxb1NQNHcyemIyT3c1V2tWM05WNDRKc3F3dHVGamowcEJicUtJSUFRREtfRGJ2Rk02NDBma2tGVVRBUmdZempRbXV0WnROSFhEQTJVLTd3YWtuQnFzT01aS2hiaENsck54VHlrV3lDWjh5eElGcWVRTTlBazY2NVk2Mmlhb3YtQ01ram9IVWFxVDhISGJYOWYzcmw3?oc=5" target="_blank">Reveal Genomics® to Evaluate Prospective Real-time Performance of HER2DX® Genomic Test in the United States</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
HER2DX Can Be Used to Diagnose HER2-Positive Breast Cancer
DocWireNewsgeneral

HER2DX Can Be Used to Diagnose HER2-Positive Breast Cancer

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNbU5fcnVfUWVrUktvbm1qQXpKQTN4LXNieWxXamJIRVZKZVNqTDBsSC1hSHc0Qk1aa3M0RnZaRURBQmxDazBubnJnT196M0xOOXRpajViMzNHa0ZnQUViUzdRV2t2RXA4Z0dENEZ6VWRiNHNqRFZWQlNLYWZReERILVJTYzBzZ1lSYVFvUmdaemhGRDRvUEtiaWU5dV9Edi1XWTZXcHVTQmVEVHBydG04WWVhQ2UxRGJP?oc=5" target="_blank">HER2DX Can Be Used to Diagnose HER2-Positive Breast Cancer</a>  <font color="#6f6f6f">DocWireNews</font>

Read Full StoryMore like this
"HER2DX in older patients" — Live Google News Trends & Headlines